Ballantyne CM - Search Results

1

Residual Cardiovascular Risk at Low LDL: Remnants, Lipoprotein(a), and Inflammation.

Hoogeveen RC, Ballantyne CM. Hoogeveen RC, et al. Among authors: ballantyne cm. Clin Chem. 2021 Jan 8;67(1):143-153. doi: 10.1093/clinchem/hvaa252. Clin Chem. 2021. PMID: 33257928 Free PMC article. Review.

2

Current thinking in lipid lowering.

Ballantyne CM. Ballantyne CM. Am J Med. 1998 Jun 22;104(6A):33S-41S. doi: 10.1016/s0002-9343(98)00186-7. Am J Med. 1998. PMID: 9684850 Review.

3

Low-density lipoproteins and risk for coronary artery disease.

Ballantyne CM. Ballantyne CM. Am J Cardiol. 1998 Nov 5;82(9A):3Q-12Q. doi: 10.1016/s0002-9149(98)00769-3. Am J Cardiol. 1998. PMID: 9819098 Review.

4

Inflammation and lipid-lowering treatment.

Ballantyne CM, Abe Y. Ballantyne CM, et al. Curr Cardiol Rep. 1999 Sep;1(3):251-5. doi: 10.1007/s11886-999-0031-y. Curr Cardiol Rep. 1999. PMID: 10980850 Review.

5

Treating mixed dyslipidemias: why and how.

Ballantyne CM. Ballantyne CM. Clin Cardiol. 2001;24(7 Suppl):II-6-9. doi: 10.1002/clc.4960240704. Clin Cardiol. 2001. PMID: 11444652 Free PMC article. Review.

6

Effect of sirolimus on the metabolism of apoB100- containing lipoproteins in renal transplant patients.

Hoogeveen RC, Ballantyne CM, Pownall HJ, Opekun AR, Hachey DL, Jaffe JS, Oppermann S, Kahan BD, Morrisett JD. Hoogeveen RC, et al. Among authors: ballantyne cm. Transplantation. 2001 Oct 15;72(7):1244-50. doi: 10.1097/00007890-200110150-00011. Transplantation. 2001. PMID: 11602850

7

Effects of sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients.

Morrisett JD, Abdel-Fattah G, Hoogeveen R, Mitchell E, Ballantyne CM, Pownall HJ, Opekun AR, Jaffe JS, Oppermann S, Kahan BD. Morrisett JD, et al. Among authors: ballantyne cm. J Lipid Res. 2002 Aug;43(8):1170-80. J Lipid Res. 2002. PMID: 12177161 Free article.

8

Familial hypercholesterolaemia: optimum treatment strategies.

Ballantyne CM. Ballantyne CM. Int J Clin Pract Suppl. 2002 Jul;(130):22-6. Int J Clin Pract Suppl. 2002. PMID: 12296605 Review.

9

Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study.

Duncan BB, Schmidt MI, Pankow JS, Ballantyne CM, Couper D, Vigo A, Hoogeveen R, Folsom AR, Heiss G; Atherosclerosis Risk in Communities Study. Duncan BB, et al. Among authors: ballantyne cm. Diabetes. 2003 Jul;52(7):1799-805. doi: 10.2337/diabetes.52.7.1799. Diabetes. 2003. PMID: 12829649

10

Leptin and incident type 2 diabetes: risk or protection?

Schmidt MI, Duncan BB, Vigo A, Pankow JS, Couper D, Ballantyne CM, Hoogeveen RC, Heiss G; ARIC Investigators. Schmidt MI, et al. Among authors: ballantyne cm. Diabetologia. 2006 Sep;49(9):2086-96. doi: 10.1007/s00125-006-0351-z. Epub 2006 Jul 19. Diabetologia. 2006. PMID: 16850292

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,021 results

Search Page